Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178932 · ClinicalTrials.gov registry record · NA
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT00178932 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 37 participants.
The verdict
NCT00178932, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
The goals of this study are to replicate previous findings of genetic predictors of response to clozapine and other antipsychotic drugs.
Interventions
- PROCEDURE genetic analysis
- PROCEDURE genetic assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 1998-11 |
| Est. Completion | 2024-05-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00178932
The ClinicalTrials.gov registry entry for NCT00178932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which genetic analysis is the first listed.
NCT00178932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00178932 about?
NCT00178932 is a clinical study titled "Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors". The goals of this study are to replicate previous findings of genetic predictors of response to clozapine and other antipsychotic drugs.
What is the current status of trial NCT00178932?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 1998-11. Estimated completion is 2024-05-16.
What interventions are being tested in trial NCT00178932?
The interventions under investigation include: genetic analysis (PROCEDURE), genetic assay (PROCEDURE).
Who is sponsoring clinical trial NCT00178932?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.